Yale University STEP-ED Study: Reducing Duration of Untreated Psychosis and Its Impact in the U.S.

Purpose: The guiding questions for this study are: can a U.S. adaptation of a successful Scandinavian approach to early detection substantially reduce the duration of untreated psychosis (DUP) and improve outcomes beyond an established first-episode service (FES)?

The primary aim of this study is to determine whether an early detection intervention can reduce the duration of untreated psychosis in the US, as compared to usual detection; as well as to determine whether the duration of untreated psychosis reduction can augment the outcomes of established 'first-episode' services on outcomes in the U.S. The investigators will measure symptoms, functioning and engagement with treatment at entry and over 1 year at each site.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Ages Eligible for Study: 16 Years to 35 Years

Contacts: Philip Markovich, B.A. 203-974-7043, philip.markovich@yale.edu

Please refer to this study by its ClinicalTrials.gov identifier: NCT02069925

Read More…

Scroll to top